Related references
Note: Only part of the references are listed.Novel Interaction of Ornithine Decarboxylase with Sepiapterin Reductase Regulates Neuroblastoma Cell Proliferation
Ingo Lange et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Polyamines Are Oncometabolites That Regulate the LIN28/let-7 Pathway in Colorectal Cancer Cells
Edwin A. Paz et al.
MOLECULAR CARCINOGENESIS (2014)
AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport
Katherine Samal et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
Susan G. Kreissman et al.
LANCET ONCOLOGY (2013)
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
Nai-Kong V. Cheung et al.
NATURE REVIEWS CANCER (2013)
PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma
Joanna E. Gawecka et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients With Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641
Douglas R. Strother et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A tumour suppressor network relying on the polyamine-hypusine axis
Claudio Scuoppo et al.
NATURE (2012)
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
Jan J. Molenaar et al.
NATURE GENETICS (2012)
Expression of Eukaryotic Initiation Factor 5A and Hypusine Forming Enzymes in Glioblastoma Patient Samples: Implications for New Targeted Therapies
Michael Preukschas et al.
PLOS ONE (2012)
Functional significance of eIF5A and its hypusine modification in eukaryotes
M. H. Park et al.
AMINO ACIDS (2010)
Cancer Chemoprevention Locks onto a New Polyamine Metabolic Target
Eugene W. Gerner
CANCER PREVENTION RESEARCH (2010)
Subcellular distribution and expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in malignant glioma: Influence on cell survival and migration
Tamas Borsics et al.
CANCER SCIENCE (2010)
Neuroblastoma: Biology, Prognosis, and Treatment
Julie R. Park et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients
Paolo Fardin et al.
MOLECULAR CANCER (2010)
Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma.
David L. Baker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Targeting Ornithine Decarboxylase Impairs Development of MYCN-Amplified Neuroblastoma
Robert J. Rounbehler et al.
CANCER RESEARCH (2009)
Mammalian Polyamine Metabolism and Function
Anthony E. Pegg
IUBMB LIFE (2009)
Involvement of Eukaryotic Translation Initiation Factor 5A (eIF5A) in Skeletal Muscle Stem Cell Differentiation
Augusto D. Luchessi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Poor Survival for Infants With MYCN-Amplified Metastatic Neuroblastoma Despite Intensified Treatment: The International Society of Paediatric Oncology European Neuroblastoma Experience
Adela Canete et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma
Dana-Lynn T. Koomoa et al.
MOLECULAR CANCER THERAPEUTICS (2009)
NCBI GEO: archive for high-throughput functional genomic data
Tanya Barrett et al.
NUCLEIC ACIDS RESEARCH (2009)
Ornithine Decarboxylase Inhibition by α-Difluoromethylornithine Activates Opposing Signaling Pathways via Phosphorylation of Both Akt/Protein Kinase B and p27Kip1 in Neuroblastoma
Dana-Lynn T. Koomoa et al.
CANCER RESEARCH (2008)
ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma
Michael D. Hogarty et al.
CANCER RESEARCH (2008)
The MSX1 homeobox transcription factor is a downstream target of PHOM and activates the Delta-Notch pathway in neuroblastoma
Ingrid Revet et al.
EXPERIMENTAL CELL RESEARCH (2008)
Expression of prenylated rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: Correlation with clinical features, cellular localization, and Cerulenin-Mediated apoptosis regulation
Dirk Geerts et al.
CLINICAL CANCER RESEARCH (2007)
Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases
Robert A. Casero et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Polyamines and neoplastic growth
A. E. Pegg et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Naturally occurring polyamines: Interaction with macromolecules
U Bachrach
CURRENT PROTEIN & PEPTIDE SCIENCE (2005)
Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells
CJ Wallick et al.
ONCOGENE (2005)
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma
A Slack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Polyamines and cancer: Old molecules, new understanding
EW Gerner et al.
NATURE REVIEWS CANCER (2004)
Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma
BH Kushner et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Statistics review 12: Survival analysis
V Bewick et al.
CRITICAL CARE (2004)
A perspective of polyamine metabolism
HM Wallace et al.
BIOCHEMICAL JOURNAL (2003)
Neuroblastoma: biology and molecular and chromosomal pathology
M Schwab et al.
LANCET ONCOLOGY (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Effect of N1-guanyl-1,7-diaminoheptane, an inhibitor of deoxyhypusine synthase, on endothelial cell growth, differentiation and apoptosis
Y Lee et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Aminohexanoic hydroxamate is a potent inducer of the differentiation of mouse neuroblastoma cells
JB Lu et al.
CANCER LETTERS (2000)
Share Paper
